Publications by authors named "Unai Aranda"

Claim this Profile
C
Cardiovascular and renal outcomes according to KDIGO stages of chronic kidney disease in the Spanish population: Insights from real-world evidence.
Rafael Santamaria, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel

Nefrologia (Engl Ed)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review.
Christoph Wanner, Ming-Hui Zhao, Alpesh N Amin, Luca De Nicola, Andrew J Sauer, Unai Aranda

Adv Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnitude of chronic kidney disease in Spain.
Rafael Santamaria, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel

Nefrologia (Engl Ed)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project.
Juan F Navarro González, Alberto Ortiz, Ana Cebrián Cuenca, Marta Moreno Barón, Lluís Segú, Unai Aranda

Nefrologia (Engl Ed)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis.
Juan Francisco Navarro-González, Alberto Ortiz, Ana Cebrián Cuenca, Lluís Segú, Belén Pimentel, Unai Aranda

Nefrologia (Engl Ed)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study.
Carlos Escobar, Beatriz Palacios, Miriam Villarreal, Martín Gutiérrez, Margarita Capel, Unai Aranda

J Clin Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk.
Ana Cebrian, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel

Nefrologia (Engl Ed)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain.
Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Antoni Sicras

Nefrologia (Engl Ed)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of outcomes in a Spanish population with chronic kidney disease.
Roberto Alcázar, Carlos Escobar, Beatriz Palacios, Unai Aranda, Luis Varela

Clin Kidney J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease.
Ana Cebrian, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel

Clin Kidney J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and healthcare utilisation of patients with chronic kidney disease in Spain.
Carlos Escobar, Beatriz Palacios, Unai Aranda, Margarita Capel, Antoni Sicras

BMC Health Serv Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain.
Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Antoni Sicras

Nefrologia (Engl Ed)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin in combination with oral agents in young and overweight/obese Type 2 diabetes mellitus patients: A pooled analysis of three randomized trials.
Irene Romera, Ramon Gomis, Susanne Crowe, Pedro de Pablos-Velasco, Unai Aranda

J Diabetes Complications· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis